Founder and 12-Year Survivor, Flora
Migyanka, Announces Significant Funding to Propel Research
and Collaboration with University of
Michigan, UPMC, and Leading Researchers.
PLYMOUTH, Mich., June 27,
2024 /PRNewswire/ -- The Dynami Foundation, a
non-profit organization dedicated to advancing research and
treatment for lobular breast cancer, is proud to announce the
presentation of a $300,000 grant to
support ongoing research and prevention efforts. This grant will
fund critical studies and foster collaboration among top
researchers at the University of
Michigan, UPMC, and other leading institutions.
Founded by Flora Migyanka, a
12-year survivor of lobular breast cancer, The Dynami Foundation is
committed to changing the landscape of breast cancer research.
Despite being a common subtype of hormone-positive breast cancer,
lobular breast cancer receives less than 1% of the total research
funding. This substantial grant aims to address this disparity and
drive forward the understanding and treatment of this disease.
"I founded The Dynami Foundation with a mission to improve the
statistics and outcomes for lobular breast cancer patients," said
Flora Migyanka, Founder and
President of The Dynami Foundation. "As a survivor, I have
witnessed firsthand the challenges and gaps in research that
patients face. This grant is a significant step toward moving the
research needle and ensuring that lobular breast cancer receives
the attention it deserves."
The $300,000 grant will be
utilized to support a range of initiatives, including:
- Innovative Research Projects: Funding groundbreaking
studies that explore the unique characteristics and treatment
responses of lobular breast cancer.
- Collaborative Efforts: Fostering partnerships between
leading researchers at the University of Michigan, UPMC, and
other top institutions to share knowledge and accelerate
discoveries.
- Clinical Trials: Supporting the development and
implementation of clinical trials that test new therapies and
treatment protocols tailored specifically for lobular breast
cancer.
Dr. Jacqueline Jeruss, Associate
Vice President for Research - Integrity and Compliance at the
University of Michigan, Associate Dean
for Regulatory Affairs and Professor of Surgery, Pathology, and
Biomedical Engineering at the University of
Michigan Medical School expressed enthusiasm for the
collaboration, stating, "This grant from The Dynami Foundation
provides a critical opportunity to deepen our understanding of
lobular breast cancer and develop more effective treatments. We are
incredibly grateful for the support and look forward to making
significant strides in our research."
UPMC's Dr Steffi Oesterreich,
Professor at University Pittsburgh, Co-Leader of Cancer Biology
Program at UPMC Hillman Cancer Center, and Co-Director of the
Women's Cancer Research Center a collaboration between UPMC, HCC,
and Magee Womens Research Institute echoed this sentiment,
highlighting the importance of dedicated funding for this
under-researched subtype of breast cancer. "Lobular breast cancer
has unique challenges that require targeted research efforts. The
Dynami Foundation's commitment is crucial for advancing our
knowledge and improving patient outcomes."
The Dynami Foundation's dedication to changing the statistics
for lobular breast cancer is unwavering. This grant represents a
major investment in the future of breast cancer research, offering
hope and progress for the thousands of patients affected by this
disease.
For more information about The Dynami Foundation and its
mission, please visit www.dynamifoundation.org or contact
info@uncorkforacure.org.
Media Contact:
Jill Giacomino
jill@socialgatheringco.com
Flora Migyanka
Founder and President
The Dynami Foundation
View original content to download
multimedia:https://www.prnewswire.com/news-releases/michigans-the-dynami-foundation-presents-300-000-grant-for-lobular-breast-cancer-research-302183674.html
SOURCE The Dynami Foundation